Cargando…
A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection
To establish a model based on inflammation index and tumor burden score (TBS) to predict recurrence of hepatocellular carcinoma (HCC) after liver resection. A retrospective study was performed on 217 patients who diagnosed HCC underwent liver resection at Xiangya Hospital Central South University fr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126887/ https://www.ncbi.nlm.nih.gov/pubmed/35606395 http://dx.doi.org/10.1038/s41598-022-12518-5 |
_version_ | 1784712228023304192 |
---|---|
author | Wang, Jianhua Chen, Zeguo Wang, Liheng Feng, Sijia Qiu, Qixuan Chen, Dongdong Li, Nianfeng Xiao, Yao |
author_facet | Wang, Jianhua Chen, Zeguo Wang, Liheng Feng, Sijia Qiu, Qixuan Chen, Dongdong Li, Nianfeng Xiao, Yao |
author_sort | Wang, Jianhua |
collection | PubMed |
description | To establish a model based on inflammation index and tumor burden score (TBS) to predict recurrence of hepatocellular carcinoma (HCC) after liver resection. A retrospective study was performed on 217 patients who diagnosed HCC underwent liver resection at Xiangya Hospital Central South University from June 1, 2017 to June 1, 2019. According to the receiver operating characteristic (ROC) curve, the optimal cut-off value of inflammatory index and the TBS was determined by the Youden index. Prediction performance was compared by the area under the receiver operating characteristic curve (AUC). Cox regression analysis was used to determine the risk factors for the recurrence of HCC after liver resection. According to the independent risk factors of the patients, a prediction model for HCC was established based on inflammation index and tumor burden score (TBS).The prediction performance of the model was compared with single index (TBS group and NLR group) and traditional HCC stage models (TNM stage and BCLC stage). MLR = 0.39, NLR = 2.63, PLR = 134, SII = 428 and TBS = 8.06 are the optimal cut-off values. AUC of SII, PLR, NLR, MLR and TBS were 0.643, 0.642, 0.642, 0.618 and 0.724respectively. MVI (P = 0.005), satellite nodule (P = 0.017), BCLC B-C stage (P = 0.013), NLR > 2.63 (P = 0.013), TBS > 8.06 (P = 0.017) are independent risk factors for the recurrence of HCC after liver resection. According to this study, the optimal inflammatory index NLR combined with TBS was obtained. The AUC of NLR–TBS model was 0.762, not only better than NLR group (AUC = 0.630) and TBS group (AUC = 0.671), also better than traditional BCLC (AUC = 0.620) and TNM (AUC = 0.587) stage models. Interestingly, we found that NLR and TBS should be good prognostic factor for recurrence of HCC after liver resection. The NLR–TBS model based the best inflammatory index (NLR) and TBS have a better prediction performance and the prediction performance of NLR–TBS model not only better than NLR group and TBS group, but better than BCLC and TNM stage models. |
format | Online Article Text |
id | pubmed-9126887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-91268872022-05-25 A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection Wang, Jianhua Chen, Zeguo Wang, Liheng Feng, Sijia Qiu, Qixuan Chen, Dongdong Li, Nianfeng Xiao, Yao Sci Rep Article To establish a model based on inflammation index and tumor burden score (TBS) to predict recurrence of hepatocellular carcinoma (HCC) after liver resection. A retrospective study was performed on 217 patients who diagnosed HCC underwent liver resection at Xiangya Hospital Central South University from June 1, 2017 to June 1, 2019. According to the receiver operating characteristic (ROC) curve, the optimal cut-off value of inflammatory index and the TBS was determined by the Youden index. Prediction performance was compared by the area under the receiver operating characteristic curve (AUC). Cox regression analysis was used to determine the risk factors for the recurrence of HCC after liver resection. According to the independent risk factors of the patients, a prediction model for HCC was established based on inflammation index and tumor burden score (TBS).The prediction performance of the model was compared with single index (TBS group and NLR group) and traditional HCC stage models (TNM stage and BCLC stage). MLR = 0.39, NLR = 2.63, PLR = 134, SII = 428 and TBS = 8.06 are the optimal cut-off values. AUC of SII, PLR, NLR, MLR and TBS were 0.643, 0.642, 0.642, 0.618 and 0.724respectively. MVI (P = 0.005), satellite nodule (P = 0.017), BCLC B-C stage (P = 0.013), NLR > 2.63 (P = 0.013), TBS > 8.06 (P = 0.017) are independent risk factors for the recurrence of HCC after liver resection. According to this study, the optimal inflammatory index NLR combined with TBS was obtained. The AUC of NLR–TBS model was 0.762, not only better than NLR group (AUC = 0.630) and TBS group (AUC = 0.671), also better than traditional BCLC (AUC = 0.620) and TNM (AUC = 0.587) stage models. Interestingly, we found that NLR and TBS should be good prognostic factor for recurrence of HCC after liver resection. The NLR–TBS model based the best inflammatory index (NLR) and TBS have a better prediction performance and the prediction performance of NLR–TBS model not only better than NLR group and TBS group, but better than BCLC and TNM stage models. Nature Publishing Group UK 2022-05-23 /pmc/articles/PMC9126887/ /pubmed/35606395 http://dx.doi.org/10.1038/s41598-022-12518-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Wang, Jianhua Chen, Zeguo Wang, Liheng Feng, Sijia Qiu, Qixuan Chen, Dongdong Li, Nianfeng Xiao, Yao A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection |
title | A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection |
title_full | A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection |
title_fullStr | A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection |
title_full_unstemmed | A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection |
title_short | A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection |
title_sort | new model based inflammatory index and tumor burden score (tbs) to predict the recurrence of hepatocellular carcinoma (hcc) after liver resection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126887/ https://www.ncbi.nlm.nih.gov/pubmed/35606395 http://dx.doi.org/10.1038/s41598-022-12518-5 |
work_keys_str_mv | AT wangjianhua anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT chenzeguo anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT wangliheng anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT fengsijia anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT qiuqixuan anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT chendongdong anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT linianfeng anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT xiaoyao anewmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT wangjianhua newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT chenzeguo newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT wangliheng newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT fengsijia newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT qiuqixuan newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT chendongdong newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT linianfeng newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection AT xiaoyao newmodelbasedinflammatoryindexandtumorburdenscoretbstopredicttherecurrenceofhepatocellularcarcinomahccafterliverresection |